Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex
- PMID: 25220416
- DOI: 10.1038/onc.2014.240
Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex
Abstract
c-Myc transcription factor is a key protein involved in cellular growth, proliferation and metabolism. c-Myc is one of the most frequently activated oncogenes, highlighting the need to identify intracellular molecules that interact directly with c-Myc to suppress its function. Here we show that Hhex is able to interact with the basic region/helix-loop-helix/leucine zipper of c-Myc. Knockdown of Hhex increases proliferation rate in hepatocellular carcinoma cells, whereas Hhex expression cell-autonomously reduces cell proliferation rate in multiple cell lines by increasing G1 phase length through a c-Myc-dependent mechanism. Global transcriptomic analysis shows that Hhex counter-regulates multiple c-Myc targets involved in cell proliferation and metabolism. Concomitantly, Hhex expression leads to reduced cell size, lower levels of cellular RNA, downregulation of metabolism-related genes, decreased sensitivity to methotrexate and severe reduction in the ability to form tumours in nude mouse xenografts, all indicative of decreased c-Myc activity. Our data suggest that Hhex is a novel regulator of c-Myc function that limits c-Myc activity in transformed cells.
Similar articles
-
A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.Med Oncol. 2012 Jun;29(2):1059-67. doi: 10.1007/s12032-011-9989-6. Epub 2011 Jun 8. Med Oncol. 2012. PMID: 21656028
-
Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.FASEB J. 2016 Jan;30(1):262-75. doi: 10.1096/fj.15-277749. Epub 2015 Sep 1. FASEB J. 2016. PMID: 26330493 Free PMC article.
-
SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.Hepatology. 2012 Dec;56(6):2277-87. doi: 10.1002/hep.25933. Hepatology. 2012. PMID: 22767186
-
Myc target miRs and liver cancer: small molecules to get Myc sick.Gastroenterology. 2012 Feb;142(2):214-8. doi: 10.1053/j.gastro.2011.12.023. Epub 2011 Dec 16. Gastroenterology. 2012. PMID: 22178210 Review. No abstract available.
-
Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases.Mediators Inflamm. 2015;2015:276850. doi: 10.1155/2015/276850. Epub 2015 Oct 5. Mediators Inflamm. 2015. PMID: 26508814 Free PMC article. Review.
Cited by
-
Walnut phenolic extracts reduce telomere length and telomerase activity in a colon cancer stem cell model.Nutr Res Pract. 2019 Feb;13(1):58-63. doi: 10.4162/nrp.2019.13.1.58. Epub 2018 Dec 3. Nutr Res Pract. 2019. PMID: 30788057 Free PMC article.
-
Computational analysis of MYC gene variants: structural and functional impact of non-synonymous SNPs.J Appl Genet. 2024 Dec 14. doi: 10.1007/s13353-024-00929-1. Online ahead of print. J Appl Genet. 2024. PMID: 39673052
-
Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.Oncogenesis. 2017 Jun 12;6(6):e346. doi: 10.1038/oncsis.2017.42. Oncogenesis. 2017. PMID: 28604763 Free PMC article.
-
A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies.Stem Cell Res Ther. 2023 Apr 18;14(1):94. doi: 10.1186/s13287-023-03311-w. Stem Cell Res Ther. 2023. PMID: 37072803 Free PMC article.
-
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.Front Immunol. 2024 Feb 8;15:1324045. doi: 10.3389/fimmu.2024.1324045. eCollection 2024. Front Immunol. 2024. PMID: 38390324 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases